ANNUAL RESULTS
Piramal Pharma Ltd.
BSE
Jun 20, 04:01
195.65
+3.65 (+ 1.90%)
Volume
62476
Prev. Close
192.00
Open Price
192.85
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Jun 20, 03:49
195.10
+3.07 (+ 1.60%)
Volume
3919727
Prev. Close
192.03
Open Price
192.49
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
195.10 (574)
You can view the
Annual Results
for the last 5 years.
|
ISIN No
|
INE0DK501011
|
Market Cap. ( ₹ in Cr. )
|
25933.63
|
P/BV
|
3.28
|
Book Value ( ₹ )
|
59.53
|
|
BSE Code
|
543635
|
52 Week High/Low ( ₹ )
|
308/145
|
FV/ML
|
10/1
|
P/E(X)
|
284.82
|
|
NSE Code
|
PPLPHARMAEQ
|
Book Closure
|
16/07/2025
|
EPS ( ₹ )
|
0.69
|
Div Yield (%)
|
0.00
|
(₹ in Crs.)
| Net Sales/Income from operations | 5285.71 | 4390.11 | 3443.22 | 2977.57 | 2899.75 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 117.38 | 39.06 |
| Total Income From Operations | 5285.71 | 4390.11 | 3443.22 | 3094.95 | 2938.81 |
| | | | | | |
| EXPENDITURE | | | | | |
| Consumption of Raw Materials | 1596.93 | 1545.55 | 1166.48 | 1003.68 | 986.70 |
| Purchase of Traded Goods | 733.60 | 624.91 | 548.69 | 509.70 | 183.21 |
| Increase/Decrease in Stocks | -84.57 | -61.62 | 53.31 | -30.17 | 57.86 |
| Employees Cost | 736.19 | 613.93 | 548.50 | 425.30 | 395.15 |
| Depreciation | 222.09 | 205.26 | 192.08 | 130.64 | 143.64 |
| Other Expenses | 1263.12 | 1049.42 | 1028.71 | 789.14 | 696.96 |
| Total Expenses | 4467.36 | 3977.45 | 3537.77 | 2828.29 | 2463.52 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 818.35 | 412.66 | -94.55 | 266.66 | 475.29 |
| Other Income | 207.35 | 202.06 | 341.07 | 223.59 | 197.97 |
| P/L Before Interest, Excpt. Items & Tax | 1025.70 | 614.72 | 246.52 | 490.25 | 673.26 |
| Interest | 114.56 | 107.10 | 115.87 | 53.55 | 4.71 |
| P/L Before Exceptional Items & Tax | 911.14 | 507.62 | 130.65 | 436.70 | 668.55 |
| Exceptional Items | 0.00 | 0.00 | -6.96 | -12.47 | 18.23 |
| P/L Before Tax | 911.14 | 507.62 | 123.69 | 424.23 | 686.78 |
| Tax | 219.74 | 116.40 | 54.19 | 81.18 | 115.28 |
| P/L After Tax from Ordinary Activities | 691.40 | 391.22 | 69.50 | 343.05 | 571.50 |
| Net Profit/Loss For the Period | 691.40 | 391.22 | 69.50 | 343.05 | 571.50 |
| | | | | | |
| Equity Share Capital | 1324.35 | 1322.95 | 1193.32 | 1185.91 | 994.60 |
| Reserves And Surplus | 6128.19 | 5389.12 | 4068.47 | 3881.43 | 3105.92 |
| Equity Dividend Rate | 1.40 | 1.10 | 0.00 | 0.00 | 0.00 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 5.22 | 3.05 | 0.58 | 2.91 | 9.11 |
| Diluted EPS (Rs.) | 5.20 | 3.05 | 0.58 | 2.91 | 9.11 |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 5.22 | 3.05 | 0.58 | 2.91 | 9.11 |
| Diluted EPS (Rs.) | 5.20 | 3.05 | 0.58 | 2.91 | 9.11 |
| | | | | | |
| PBITOE Margin (%) | 15.48 | 9.39 | -2.74 | 8.61 | 16.17 |
| PBTE Margin (%) | 17.23 | 11.56 | 3.79 | 14.11 | 22.74 |
| PBT Margin (%) | 17.23 | 11.56 | 3.59 | 13.70 | 23.36 |
| PAT Margin (%) | 13.08 | 8.91 | 2.01 | 11.08 | 19.44 |